Generics Has Gained Full Through Azathioprine States - Nov 20, 2008

Glenmark Generics has gained full marketing rights through an exclusive partnership to begin distributing Azathioprine 50 mg tablets in the United States.Azathioprine is the generic equivalent of Imuran tablets and is indicated as an adjunct for the prevention of rejection in renal homotransplantations (kidney transplantation) It is also indicated for the management of active rheumatoid arthritis to reduce signs and symptoms. Total sales for the 12 month period ending June 2008 were approximately $36 million as stated by IMS Health.

This product launch signifies Glenmark's commitment to enhance and augment its current portfolio of internal filings through the addition of external partnerships. Today, Glenmark is authorized to distribute 130 SKUs in the U.S. marketplace. The company currently has 40 ANDAs in various stages of the approval process with U.S.FDA.The company made this announcement during the trading hours today, 20 November 2008.